Seguimiento del cáncer de cabeza y cuello tratado. Lo que el radiólogo debe conocer / Follow-up in head and neck cancer. What the radiologist must know

El manejo de los pacientes con cáncer de cabeza y cuello implica un tratamiento multidisciplinar con cirugía, radioterapia y quimioterapia. Las pruebas de imagen son cruciales en su seguimiento, sobre todo cuando la recurrencia tumoral no sea clínicamente evidente. Distinguir radiológicamente los cambios postratamiento de una recidiva tumoral constituye un reto debido a la alteración anatómica que suponen las técnicas quirúrgicas y sus reconstrucciones, al tratamiento radioterápico y a las pautas quimioterápicas. El diagnóstico diferencial debe incluir las posibles complicaciones derivadas de la radioterapia (necrosis mucosa, osteorradionecrosis, vasculopatía, radionecrosis cerebral) y de la cirugía (infecciones de la herida, necrosis del colgajo, fístulas, etc.). Un amplio conocimiento de los hallazgos esperables del tratamiento multimodal y sus complicaciones es esencial para un diagnóstico preciso de recurrencia tumoral. Por último, elegir la prueba de imagen adecuada y disponer de un estudio basal postratamiento es igualmente relevante para un control radiológico idóneo

The management of patients with head and neck cancer implies a multidisciplinary treatment with surgery, radiotherapy and chemotherapy. Imaging is crucial in their follow-up, especially when the tumor recurrence is not clinically evident. Radiologically distinguishing post-treatment changes from a tumor recurrence is a challenge due to the anatomical alteration due to surgical techniques and their reconstructions, radiotherapy treatment and chemotherapeutic guidelines. The differential diagnosis must include the possible complications derived from radiotherapy (mucosal necrosis, osteoradionecrosis, vasculopathy, cerebral radionecrosis) and surgery (wound infections, flap necrosis, fistulas,...). A wide knowledge of the expected findings of multimodal treatment and its complications is essential for an accurate diagnosis of tumor recurrence. Finally, choosing the appropriate image study and having a baseline post-treatment study is also relevant for a suitable radiological control

Follow-up in head and neck cancer. What the radiologist must know. / Seguimiento del cáncer de cabeza y cuello tratado. Lo que el radiólogo debe conocer.

The management of patients with head and neck cancer implies a multidisciplinary treatment with surgery, radiotherapy and chemotherapy. Imaging is crucial in their follow-up, especially when the tumor recurrence is not clinically evident. Radiologically distinguishing post-treatment changes from a tumor recurrence is a challenge due to the anatomical alteration due to surgical techniques and their reconstructions, radiotherapy treatment and chemotherapeutic guidelines. The differential diagnosis must include the possible complications derived from radiotherapy (mucosal necrosis, osteoradionecrosis, vasculopathy, cerebral radionecrosis) and surgery (wound infections, flap necrosis, fistulas,...). A wide knowledge of the expected findings of multimodal treatment and its complications is essential for an accurate diagnosis of tumor recurrence. Finally, choosing the appropriate image study and having a baseline post-treatment study is also relevant for a suitable radiological control.

Neuroimagen y ensayos clínicos con células madre en la esclerosis lateral amiotrófica: perspectivas de presente y futuro / Neuroimaging and clinical trials with stem cells in amyotrophic lateral sclerosis: present and future perspectives

La esclerosis lateral amiotrófica es una enfermedad neurodegenerativa rara con un curso rápido y fatal. La ausencia de tratamientos efectivos ha hecho surgir nuevas líneas de investigación, entre ellas las basadas en células madre. La inyección quirúrgica intramedular, que ha sido la principal vía de administración, ha demostrado ser segura en los ensayos de seguridad del procedimiento. Sin embargo, persisten desafíos como la mejor vía de administración o el modo de comprobar la supervivencia de las células y su interacción con la diana terapéutica. La misión de las técnicas de neuroimagen ha sido hasta ahora la detección de lesiones y complicaciones espinales y medulares, pero tienen potencial para sustituir al estudio anatomopatológico, analizando la relación de las células implantadas con la diana terapéutica, y como biomarcadores de la enfermedad, midiendo cambios morfológicos y funcionales postratamiento, lo que implicará más a los radiólogos en el manejo clínico de estos enfermos

Amyotrophic lateral sclerosis is a rare neurodegenerative disease with a rapid fatal course. The absence of effective treatments has led to new lines of research, some of which are based on stem cells. Surgical injection into the spinal cord, the most common route of administration of stem cells, has proven safe in trials to test the safety of the procedure. Nevertheless, challenges remain, such as determining the best route of administration or the way of checking the survival of the cells and their interaction with the therapeutic target. To date, the mission of neuroimaging techniques has been to detect lesions and complications in the spine and spinal cord, but neuroimaging also has the potential to supplant histologic study in analyzing the relations between the implanted cells and the therapeutic target, and as biomarkers of the disease, by measuring morphological and functional changes after treatment. These developments would increase the role of radiologists in the clinical management of patients with amyotrophic lateral sclerosis

Neuroimaging and clinical trials with stem cells in amyotrophic lateral sclerosis: present and future perspectives. / Neuroimagen y ensayos clínicos con células madre en la esclerosis lateral amiotrófica: perspectivas de presente y futuro.

Amyotrophic lateral sclerosis is a rare neurodegenerative disease with a rapid fatal course. The absence of effective treatments has led to new lines of research, some of which are based on stem cells. Surgical injection into the spinal cord, the most common route of administration of stem cells, has proven safe in trials to test the safety of the procedure. Nevertheless, challenges remain, such as determining the best route of administration or the way of checking the survival of the cells and their interaction with the therapeutic target. To date, the mission of neuroimaging techniques has been to detect lesions and complications in the spine and spinal cord, but neuroimaging also has the potential to supplant histologic study in analyzing the relations between the implanted cells and the therapeutic target, and as biomarkers of the disease, by measuring morphological and functional changes after treatment. These developments would increase the role of radiologists in the clinical management of patients with amyotrophic lateral sclerosis.